Operating Cash Flow
Pfizer Operating Cash Flow decreased by 51.1% to $2.62B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 12.0%, from $2.34B to $2.62B. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows a downward trend with a -22.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
Consistently high operating cash flow indicates a healthy, self-sustaining business capable of funding its own growth and returning capital to shareholders.
Detailed definition
Net cash from operating activities measures the total amount of cash generated by a company's core business operations....
Peer comparison
Investors often compare this to capital expenditures to calculate Free Cash Flow, a primary valuation metric for mature tech giants.
net_cash_from_operatingHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $11.30B | $10.83B | $5.91B | $6.54B | $8.17B | $5.97B | $8.58B | $1.21B | -$1.21B | $3.46B | $5.24B | $1.09B | -$1.78B | $6.71B | $6.72B | $2.34B | -$582.00M | $4.60B | $5.35B | $2.62B |
| QoQ Change | — | -4.2% | -45.4% | +10.6% | +24.9% | -26.9% | +43.7% | -85.9% | -199.7% | +386.1% | +51.6% | -79.2% | -263.4% | +477.0% | +0.1% | -65.3% | -124.9% | +890.9% | +16.2% | -51.1% |
| YoY Change | — | — | — | — | -27.7% | -44.8% | +45.1% | -81.5% | -114.8% | -42.1% | -38.9% | -10.1% | -47.4% | +94.3% | +28.3% | +114.2% | +67.3% | -31.4% | -20.4% | +12.0% |
Operating Cash Flow at Other Companies
Frequently Asked Questions
- What is Pfizer's operating cash flow?
- Pfizer (PFE) reported operating cash flow of $2.62B in Q1 2026.
- How has Pfizer's operating cash flow changed year-over-year?
- Pfizer's operating cash flow increased by 12.0% year-over-year, from $2.34B to $2.62B.
- What is the long-term trend for Pfizer's operating cash flow?
- Over 4 years (2021 to 2025), Pfizer's operating cash flow has grown at a -22.6% compound annual growth rate (CAGR), from $32.58B to $11.70B.
- What does operating cash flow mean?
- The actual amount of cash a company brings in from its day-to-day business activities.